0001382963-15-000082.txt : 20150630 0001382963-15-000082.hdr.sgml : 20150630 20150630200937 ACCESSION NUMBER: 0001382963-15-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150629 FILED AS OF DATE: 20150630 DATE AS OF CHANGE: 20150630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RITTER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 CENTURY PARK EAST, SUITE 1820 CITY: LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 310-203-1000 MAIL ADDRESS: STREET 1: 1801 CENTURY PARK EAST, SUITE 1820 CITY: LOS ANGELES STATE: CA ZIP: 90067 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ritter Ira E. CENTRAL INDEX KEY: 0001631674 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 15962853 MAIL ADDRESS: STREET 1: C/O RITTER PHARMACEUTICALS INC. STREET 2: 1801 CENTURY PARK EAST, SUITE 1820 CITY: LOS ANGELES STATE: CA ZIP: 90096 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-06-29 0001460702 RITTER PHARMACEUTICALS INC RTTR 0001631674 Ritter Ira E. RITTER PHARMACEUTICALS, INC. 1801 CENTURY PARK EAST, #1820 LOS ANGELES CA 90067 1 1 0 0 Exec. Chairman, CSO Common Stock 2015-06-29 4 C 0 817272 A 817272 I by Stonehenge Partners LLC Convertible Preferred Stock 2015-06-29 4 C 0 817272 0 D Common Stock 817272 0 I by Stonehenge Partners LLC Effective on the date of the closing of the issuer's initial public offering, the Convertible Preferred Stock of the issuer held by Stonehenge Partners LLC converted into Common Stock of the issuer on a one-for-one basis and had no expiration date. As a managing partner of Stonehenge Partners LLC, the reporting person may be deemed the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. /s/Andrew J. Ritter, attorney-in-fact 2015-06-30